世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

再生医療市場:動向、予測、競合分析


Regenerative Medicine Market: Trends, Forecast and Competitive Analysis

再生医療市場の動向と予測 世界の再生医療市場の将来は、筋骨格系疾患、創傷治療、腫瘍学、眼疾患、糖尿病におけるビジネスチャンスで有望視されている。世界の再生医療市場は、2030年までに推定102億ドルに達... もっと見る

 

 

出版社 出版年月 電子版価格 言語
Lucintel
ルシンテル
2024年2月21日 US$4,850
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

本レポートは受注生産のため、2~3営業日程度ご納品のお時間をいただく場合がございます。


 

サマリー

再生医療市場の動向と予測

世界の再生医療市場の将来は、筋骨格系疾患、創傷治療、腫瘍学、眼疾患、糖尿病におけるビジネスチャンスで有望視されている。世界の再生医療市場は、2030年までに推定102億ドルに達すると予想され、2024年から2030年までの年平均成長率は3.0%と予測されている。この市場の主な促進要因は、個別化医療に対する人々の嗜好の高まり、研究開発活動に関する政府や民間機関による投資の増加、幹細胞治療における技術の進歩である。

再生医療市場の新たなトレンド
業界のダイナミクスに直接的な影響を与える新たなトレンドとしては、幹細胞技術の採用の増加や、組織工学・再生医療における3Dバイオプリンティング技術の利用の増加が挙げられる。

この市場では、細胞ベースの免疫・細胞療法が再生医療の最大の製品であり、筋骨格系疾患が最大の応用分野である。再生医療市場の様々なセグメントにおける成長を以下に示す:

本調査では、世界の再生医療市場について、材料別、製品別、用途別、流通チャネル別、地域別の動向と予測を以下のようにまとめた:
素材別 [2018年~2030年の金額(百万ドル)出荷分析]:
- 合成
o足場
o 人工血管グラフト材料
o ハイドロゲル材料
- 生物由来材料
o コラーゲン
o 異種材料
- 遺伝子組み換え材料
o デオキシリボ核酸トランスフェクションベクター
o 遺伝子操作された細胞
o 三次元ポリマー技術
o トランスジェニック
o 線維芽細胞
o 神経幹細胞
o 遺伝子活性化マトリックス
- 医薬品
o 低分子
o 生物製剤
製品別[2018年~2030年の金額(百万ドル)出荷分析]:
- 細胞ベースの免疫療法・細胞療法製品
- 組織工学製品
- 低分子および生物製剤
- 遺伝子治療製品
用途別[2018~2030年の出荷額(百万ドル)分析]:筋骨格系疾患
- 筋骨格系疾患
- 創傷治療
- 腫瘍学
- 眼疾患
- 糖尿病
- その他の用途
流通チャネル別[2018年~2030年の金額(百万ドル)出荷分析]
- 病院
- クリニック
- その他
地域別[2018年~2030年の出荷額(百万ドル)分析]:北米
- 北米
o 米国
o カナダ
o メキシコ
- 欧州
o イギリス
o ドイツ
o フランス
- アジア太平洋
o 中国
o インド
o 日本
- その他の地域
o ブラジル
再生医療企業のリスト
同市場の企業は、提供する製品の品質に基づいて競争している。同市場の主要企業は、製造施設の拡大、研究開発投資、インフラ整備、バリューチェーン全体にわたる統合機会の活用に注力している。これらの戦略により、再生医療企業は需要の増加に対応し、競争力を確保し、革新的な製品と技術を開発し、生産コストを削減し、顧客基盤を拡大している。本レポートで紹介する再生医療企業には、以下のようなものがある。
- カイトファーマ
- ノバルティス
- ベリセル
- インテグラ・ライフサイエンス
- ライトメディカル
- ミメデックス
- オシリス・セラピューティクス
- ストライカー
- スパーク・セラピューティクス
- ジンマー・バイオメット
再生医療市場の洞察
- Lucintel社は、細胞療法製品に関連する研究開発活動における政府支援の増加や、再生医療の承認合理化のためのFDAによるCures Actの制定により、細胞ベースの免疫学および細胞療法製品が予測期間中最大のセグメントであり続けると予測している。
- この市場の中では、整形外科疾患の増加と老人人口の増加により、筋骨格系疾患が予測期間中最大の用途別セグメントであり続けるだろう。
- 北米は、先端技術の存在と新規治療薬の開発に携わる研究機関の多さから、予測期間中も最大地域であり続けるだろう。
再生医療市場の特徴
- 市場規模の推定:再生医療市場規模を金額(百万ドル)で推計
- 動向と予測分析:各種セグメント・地域別の市場動向(2018-2023年)と予測(2024-2030年)。
- セグメンテーション分析:材料、製品、用途、流通チャネルなど様々なセグメント別の再生医療市場規模。
- 地域別分析:再生医療市場の北米、欧州、アジア太平洋、その他の地域別の内訳。
- 成長機会:再生医療市場の材料、製品、用途、流通チャネル、地域別の成長機会に関する分析。
- 戦略分析:再生医療におけるM&Aや競合状況など。
- ポーターのファイブフォースモデルに基づく業界の競争激化の分析。
よくある質問
Q1.再生医療の市場規模はどのくらいですか?
回答:世界の再生医療市場は、2030年までに102億ドルに達すると推定されています。
Q2.再生医療市場の成長予測は?
回答:再生医療市場は、2024年から2030年にかけて年平均成長率3.0%で成長すると予測されています。
Q3.再生医療市場の成長に影響を与える主なドライバーは何ですか?
回答この市場の主な促進要因は、個別化医療に対する人々の嗜好の高まり、研究開発活動に関する政府や民間機関による投資の増加、幹細胞治療における技術の進歩です。
Q4.再生医療の主な用途や最終使用産業は何ですか?
回答:病院やクリニックが再生医療の主な最終用途です。
Q5.再生医療市場の新たなトレンドは?
回答:業界のダイナミクスに直接的な影響を与える新たなトレンドとしては、幹細胞技術の採用の増加や、組織工学・再生医療における3Dバイオプリンティング技術の利用の増加が挙げられます。
Q6.主要な再生医療企業はどこですか?
回答:主要な再生医療企業は以下の通りです:
- カイトファーマ
- ノバルティス
- ベリセル
- インテグラライフサイエンス
- ライトメディカル
- ミメデックス
- オシリス・セラピューティクス
- ストライカー
- スパーク・セラピューティクス
- ジンマー・バイオメット
Q7.今後、再生医療の原料セグメントはどこが一番大きくなるのか?
回答Lucintelは、細胞治療製品に関連する研究開発活動における政府支援の増加や、再生医療の承認を合理化するためのFDAによるCures Actの制定により、細胞ベースの免疫学および細胞治療製品が予測期間中最大のセグメントであり続けると予測している。
Q8: 再生医療市場において、今後5年間で最大となる地域はどこか。
回答:今後5年間も北米が最大である。
Q9.本レポートのカスタマイズは可能ですか?
回答:はい、Lucintel は追加費用なしで 10% のカスタマイズを提供します。
本レポートは以下の11の主要な質問に回答しています。
Q.1世界の再生医療市場において、材料別(合成材料(足場材料、人工血管材料、ハイドロゲル材料)、 生物由来材料(コラーゲン、異種材料)、遺伝子操作材料(デオキシリボ核酸トランスフェクションベクター、 遺伝子操作細胞、三次元ポリマー技術、トランスジェニック、線維芽細胞、神経幹細胞、および遺伝子活性化マトリックス)、医薬品(低分子および生物製剤))、製品(細胞ベースの免疫療法および細胞療法製品、組織工学製品、低分子および生物製剤、遺伝子療法製品)、用途(筋骨格系障害、創傷治療、腫瘍学、眼疾患、糖尿病、およびその他の用途)、流通チャネル(病院、診療所、その他)、地域(北米、欧州、アジア太平洋地域、およびその他の地域)は何ですか?
Q.2 今後成長が加速するセグメントとその理由は?
Q.3 今後成長が加速する地域とその理由は?
Q.4 市場ダイナミクスに影響を与える主な要因は何ですか?市場の推進要因と課題は何か?
Q.5 市場にとってのビジネスリスクと脅威は何か?
Q.6 市場の新たなトレンドとその理由は?
Q.7 市場の顧客需要の変化にはどのようなものがありますか?
Q.8 市場の新たな動きにはどのようなものがありますか?これらの開発をリードしている企業はどこですか?
Q.9 市場の主要プレーヤーは?主要プレーヤーは事業成長のためにどのような戦略的取り組みを実施していますか?
Q.10 市場において競合する製品やプロセスにはどのようなものがあり、材料や製品の代替によって市場シェアを失う脅威はどの程度ありますか?
Q.11 この市場において、過去5年間にどのようなM&A活動が行われましたか?


ページTOPに戻る


目次

Table of Contents

2. Market Background and Classifications
2.1 Introduction, Background, and Classifications
2.2 Supply Chain
2.3 Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030
3.1 Macroeconomic Trends and Forecast
3.2 Global Regenerative Medicine Market Trends and Forecast
3.3 Global Regenerative Medicine Market by Material
3.3.1 Synthetic
3.3.1.1 Scaffold
3.3.1.2 Artificial Vascular Graft Materials
3.3.1.3 Hydrogel Materials
3.3.2 Biologically Derived Materials
3.3.2.1 Collagen
3.3.2.2 Xenogeneic Materials
3.3.3 Genetically Engineered Materials
3.3.3.1 Deoxyribonucleic Acid Transfection Vectors
3.3.3.2 Genetically Manipulated Cells
3.3.3.3 Three-dimensional Polymer Technology
3.3.3.4 Transgenics
3.3.3.5 Fibroblasts
3.3.3.6 Neural Stem Cells
3.3.3.7 Gene-activated Matrices
3.3.4 Pharmaceuticals
3.3.4.1 Small Molecules
3.3.4.2 Biologics
3.4 Global Regenerative Medicine Market by Product
3.4.1 Cell-Based Immunotherapy & Cell Therapy Products
3.4.2 Tissue-Engineered Products
3.4.3 Small Molecules And Biologics
3.4.4 Gene Therapy Products
3.5 Global Regenerative Medicine Market by Application
3.5.1 Musculoskeletal Disorders
3.5.2 Wound Care
3.5.3 Oncology
3.5.4 Ocular Disorders
3.5.5 Diabetes
3.5.6 Other Applications
3.6 Global Regenerative Medicine Market by Distribution Channel
3.6.1 Hospitals
3.6.2 Clinic
3.6.3 Others

4. Market Trends and Forecast Analysis by Region
4.1 Global Regenerative Medicine Market by Region
4.2 North American Regenerative Medicine Market
4.2.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.2.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.2.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.2.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.2.5 The United States Regenerative Medicine Market
4.2.6 The Canadian Regenerative Medicine Market
4.2.7 The Mexican Regenerative Medicine Market
4.3 European Regenerative Medicine Market
4.3.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.3.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.3.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.3.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.3.5 The Regenerative Medicine Market of the United Kingdom
4.3.6 The German Regenerative Medicine Market
4.3.7 The French Regenerative Medicine Market
4.4 APAC Regenerative Medicine Market
4.4.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.4.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.4.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.4.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.4.5 The Chinese Regenerative Medicine Market
4.4.6 The Indian Regenerative Medicine Market
4.4.7 The Japanese Regenerative Medicine Market
4.5 ROW Regenerative Medicine Market
4.5.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.5.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.5.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.5.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.5.5 Brazilian Regenerative Medicine Market

5. Competitor Analysis
5.1 Market Share Analysis
5.2 Product Portfolio Analysis
5.3 Operational Integration
5.4 Geographical Reach
5.5 Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1 Growth Opportunity Analysis
6.1.1 Growth Opportunities for the Global Regenerative Medicine Market by Material
6.1.2 Growth Opportunities for the Global Regenerative Medicine Market by Product
6.1.3 Growth Opportunities for the Global Regenerative Medicine Market by Application
6.1.4 Growth Opportunities for the Global Regenerative Medicine Market by Distribution Channel
6.1.5 Growth Opportunities for the Global Regenerative Medicine Market by Region
6.2 Emerging Trends in the Global Regenerative Medicine Market
6.3 Strategic Analysis
6.3.1 New Product Development
6.3.2 Capacity Expansion of the Global Regenerative Medicine Market
6.3.3 Mergers, Acquisitions, and Joint Ventures in the Global Regenerative Medicine Market

7. Company Profiles of Leading Players
7.1 Kite Pharma
7.2 Novartis
7.3 Vericel Corporation
7.4 Integra LifeSciences
7.5 Wright Medical
7.6 MiMedx
7.7 Osiris Therapeutics
7.8 Stryker Corporation
7.9 Spark Therapeutics
7.10 Zimmer Biomet Holdings, Inc.

 

ページTOPに戻る


 

Summary

Regenerative Medicine Market Trends and Forecast

The future of the global regenerative medicine market looks promising with opportunities in musculoskeletal disorders, wound care, oncology, ocular disorders, and diabetes. The global regenerative medicine market is expected to reach an estimated $10.2 billion by 2030, and it is forecast to grow at a CAGR of 3.0% from 2024 to 2030. The major drivers for this market are increasing preference of people for personalized medicines, rising investment by governments and private agencies regarding research and development activities, and technological advancements in stem-cell therapies.

Emerging Trends in the Regenerative Medicine Market
Emerging trends, which have a direct impact on the dynamics of the industry, include increasing adoption of stem cell technologies and increasing use of 3D bioprinting technologies in tissue engineering & regenerative medicine.

In this market, cell-based immunology & cell therapy is the largest product of regenerative medicine, whereas musculoskeletal disorders is the largest application. Growth in various segments of the regenerative medicine market are given below:

The study includes trends and forecast for the global regenerative medicine market by material, product, application, distribution channel, and region as follows:
By Material [Value ($ Million) shipment analysis for 2018 – 2030]:
• Synthetic
o Scaffold
o Artificial Vascular Graft Materials
o Hydrogel Materials
• Biologically Derived Materials
o Collagen
o Xenogeneic Materials
• Genetically Engineered Materials
o Deoxyribonucleic Acid Transfection Vectors
o Genetically Manipulated Cells
o Three-Dimensional Polymer Technology
o Transgenics
o Fibroblasts
o Neural Stem Cells
o Gene-Activated Matrices
• Pharmaceuticals
o Small Molecules
o Biologics
By Product [Value ($ Million) shipment analysis for 2018 – 2030]:
• Cell-Based Immunotherapy & Cell Therapy Products
• Tissue-Engineered Products
• Small Molecules and Biologics
• Gene Therapy Products
By Application [Value ($ Million) shipment analysis for 2018 – 2030]:
• Musculoskeletal Disorders
• Wound Care
• Oncology
• Ocular Disorders
• Diabetes
• Other Applications
By Distribution Channel [Value ($ Million) shipment analysis for 2018 – 2030]:
• Hospitals
• Clinics
• Others
By Region [Value ($ Million) shipment analysis for 2018 – 2030]:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
• Asia Pacific
o China
o India
o Japan
• The Rest of the World
o Brazil
List of Regenerative Medicine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies regenerative medicine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the regenerative medicine companies profiled in this report include.
• Kite Pharma
• Novartis
• Vericel
• Integra LifeSciences
• Wright Medical
• MiMedx
• Osiris Therapeutics
• Stryker
• Spark Therapeutics
• Zimmer Biomet
Regenerative Medicine Market Insights
• Lucintel forecasts that cell-based immunology and cell therapy products will remain the largest segment over the forecast period due to increasing government support in research and development activities related to cell therapy products and establishment of the Cures Act by FDA for streamlining the approval of regenerative medicine.
• Within this market, musculoskeletal disorders will remain the largest segment by application over the forecast period due to increasing orthopedic diseases and rising geriatric population.
• North America will remain the largest region over the forecast period due to presence of advanced technologies and a large number of research institutes involved in the development of novel therapeutics.
Features of the Regenerative Medicine Market
• Market Size Estimates: Regenerative medicine market size estimation in terms of value ($M).
• Trend and Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments and regions.
• Segmentation Analysis: Regenerative medicine market size by various segments, such as material, product, application, and distribution channel.
• Regional Analysis: Regenerative medicine market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
• Growth Opportunities: Analysis on growth opportunities in different material, product, application, distribution channel, and regions for regenerative medicine market.
• Strategic Analysis: This includes M&A and competitive landscape for the regenerative medicine .
• Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the regenerative medicine market size?
Answer:The global regenerative medicine market is expected to reach an estimated $10.2 billion by 2030.
Q2. What is the growth forecast for regenerative medicine market?
Answer:The regenerative medicine market is expected to grow at a CAGR of 3.0% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the regenerative medicine market?
Answer: The major drivers for this market are increasing preference of people for personalized medicines, rising investment by governments and private agencies regarding research and development activities, and technological advancements in stem-cell therapies.
Q4. What are the major applications or end use industries for regenerative medicine?
Answer:Hospital and clinic are the major end uses for regenerative medicine
Q5. What are the emerging trends in regenerative medicine market?
Answer:Emerging trends, which have a direct impact on the dynamics of the industry, include increasing adoption of stem cell technologies and increasing use of 3D bioprinting technologies in tissue engineering & regenerative medicine.
Q6. Who are the key regenerative medicine companies?
Answer:Some of the key regenerative medicine companies are as follows:
• Kite Pharma
• Novartis
• Vericel
• Integra LifeSciences
• Wright Medical
• MiMedx
• Osiris Therapeutics
• Stryker
• Spark Therapeutics
• Zimmer Biomet
Q7.Which regenerative medicine raw material segment will be the largest in future?
Answer: Lucintel forecasts that cell-based immunology and cell therapy products will remain the largest segment over the forecast period due to increasing government support in research and development activities related to cell therapy products and establishment of the Cures Act by FDA for streamlining the approval of regenerative medicine.
Q8: In regenerative medicine market, which region is expected to be the largest in next 5 years?
Answer:North America will remain the largest region in next 5 years.
Q9. Do we receive customization in this report?
Answer:Yes, Lucintel provides 10% Customization Without any Additional Cost.
This report answers following 11 key questions
Q.1 What are some of the most promising potential, high-growth opportunities for the global regenerative medicine market by material (synthetic (scaffold, artificial vascular graft materials, and hydrogel materials), biologically derived materials (collagen and xenogeneic materials), genetically engineered materials (deoxyribonucleic acid transfection vectors, genetically manipulated cells, three-dimensional polymer technology, transgenics, fibroblasts, neural stem cells, and gene-activated matrices), and pharmaceuticals (small molecules and biologics)), product (cell-based immunotherapy & cell therapy products, tissue-engineered products, small molecules and biologics, and gene therapy products), application (musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and other applications), distribution channel (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)?
Q. 2 Which segments will grow at a faster pace and why?
Q.3 Which region will grow at a faster pace and why?
Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the market?
Q.5 What are the business risks and threats to the market?
Q.6 What are the emerging trends in this market and the reasons behind them?
Q.7 What are some changing demands of customers in the market?
Q.8 What are the new developments in the market? Which companies are leading these developments?
Q.9 Who are the major players in this market? What strategic initiatives are being implemented by key players for business growth?
Q.10 What are some of the competitive products and processes in this market, and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11 What M & A activities did take place in the last five years in this market?



ページTOPに戻る


Table of Contents

Table of Contents

2. Market Background and Classifications
2.1 Introduction, Background, and Classifications
2.2 Supply Chain
2.3 Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030
3.1 Macroeconomic Trends and Forecast
3.2 Global Regenerative Medicine Market Trends and Forecast
3.3 Global Regenerative Medicine Market by Material
3.3.1 Synthetic
3.3.1.1 Scaffold
3.3.1.2 Artificial Vascular Graft Materials
3.3.1.3 Hydrogel Materials
3.3.2 Biologically Derived Materials
3.3.2.1 Collagen
3.3.2.2 Xenogeneic Materials
3.3.3 Genetically Engineered Materials
3.3.3.1 Deoxyribonucleic Acid Transfection Vectors
3.3.3.2 Genetically Manipulated Cells
3.3.3.3 Three-dimensional Polymer Technology
3.3.3.4 Transgenics
3.3.3.5 Fibroblasts
3.3.3.6 Neural Stem Cells
3.3.3.7 Gene-activated Matrices
3.3.4 Pharmaceuticals
3.3.4.1 Small Molecules
3.3.4.2 Biologics
3.4 Global Regenerative Medicine Market by Product
3.4.1 Cell-Based Immunotherapy & Cell Therapy Products
3.4.2 Tissue-Engineered Products
3.4.3 Small Molecules And Biologics
3.4.4 Gene Therapy Products
3.5 Global Regenerative Medicine Market by Application
3.5.1 Musculoskeletal Disorders
3.5.2 Wound Care
3.5.3 Oncology
3.5.4 Ocular Disorders
3.5.5 Diabetes
3.5.6 Other Applications
3.6 Global Regenerative Medicine Market by Distribution Channel
3.6.1 Hospitals
3.6.2 Clinic
3.6.3 Others

4. Market Trends and Forecast Analysis by Region
4.1 Global Regenerative Medicine Market by Region
4.2 North American Regenerative Medicine Market
4.2.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.2.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.2.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.2.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.2.5 The United States Regenerative Medicine Market
4.2.6 The Canadian Regenerative Medicine Market
4.2.7 The Mexican Regenerative Medicine Market
4.3 European Regenerative Medicine Market
4.3.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.3.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.3.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.3.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.3.5 The Regenerative Medicine Market of the United Kingdom
4.3.6 The German Regenerative Medicine Market
4.3.7 The French Regenerative Medicine Market
4.4 APAC Regenerative Medicine Market
4.4.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.4.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.4.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.4.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.4.5 The Chinese Regenerative Medicine Market
4.4.6 The Indian Regenerative Medicine Market
4.4.7 The Japanese Regenerative Medicine Market
4.5 ROW Regenerative Medicine Market
4.5.1 Market by Material: Synthetic (Scaffold, Artificial Vascular Graft Materials, and Hydrogel Materials), Biologically Derived Materials (Collagen and Xenogeneic Materials), Genetically Engineered Materials (Deoxyribonucleic Acid Transfection Vectors, Genetically Manipulated Cells, Three-dimensional Polymer Technology, Transgenics, Fibroblasts, Neural Stem Cells, and Gene-activated Matrices), Pharmaceuticals (Small Molecules and Biologics)
4.5.2 Market by Product: Cell-Based Immunotherapy & Cell Therapy Products, Tissue-Engineered Products, Small Molecules and Biologics, and Gene Therapy Products
4.5.3 Market by Application: Musculoskeletal Disorders, Wound Care, Oncology, Ocular Disorders, Diabetes, and Other Applications
4.5.4 Market by Distribution Channel: Hospitals, Clinics, and Others
4.5.5 Brazilian Regenerative Medicine Market

5. Competitor Analysis
5.1 Market Share Analysis
5.2 Product Portfolio Analysis
5.3 Operational Integration
5.4 Geographical Reach
5.5 Porter’s Five Forces Analysis

6. Growth Opportunities and Strategic Analysis
6.1 Growth Opportunity Analysis
6.1.1 Growth Opportunities for the Global Regenerative Medicine Market by Material
6.1.2 Growth Opportunities for the Global Regenerative Medicine Market by Product
6.1.3 Growth Opportunities for the Global Regenerative Medicine Market by Application
6.1.4 Growth Opportunities for the Global Regenerative Medicine Market by Distribution Channel
6.1.5 Growth Opportunities for the Global Regenerative Medicine Market by Region
6.2 Emerging Trends in the Global Regenerative Medicine Market
6.3 Strategic Analysis
6.3.1 New Product Development
6.3.2 Capacity Expansion of the Global Regenerative Medicine Market
6.3.3 Mergers, Acquisitions, and Joint Ventures in the Global Regenerative Medicine Market

7. Company Profiles of Leading Players
7.1 Kite Pharma
7.2 Novartis
7.3 Vericel Corporation
7.4 Integra LifeSciences
7.5 Wright Medical
7.6 MiMedx
7.7 Osiris Therapeutics
7.8 Stryker Corporation
7.9 Spark Therapeutics
7.10 Zimmer Biomet Holdings, Inc.

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Lucintel社はどのような調査会社ですか?


Lucintelは世界の多様な市場について調査を行っています。特に化学品、材料、自動車関連の調査レポートを数多く出版しています。  もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/25 10:25

158.38 円

165.32 円

201.48 円

ページTOPに戻る